Cargando…
Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer
The methyltransferase Polycomb Repressive Complex 2 (PRC2), composed of EZH2, SUZ12, and EED subunits, is associated with transcriptional repression via tri-methylation of histone H3 on lysine 27 residue (H3K27me3). PRC2 is a valid drug target, as the EZH2 gain-of-function mutations identified in pa...
Autores principales: | Chu, Liping, Qu, Yuxiu, An, Yang, Hou, Linjun, Li, Juewan, Li, Weijia, Fan, Gaofeng, Song, Bao-Liang, Li, En, Zhang, Liye, Qi, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847585/ https://www.ncbi.nlm.nih.gov/pubmed/35169119 http://dx.doi.org/10.1038/s41419-022-04601-6 |
Ejemplares similares
-
Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023) -
Impact of senescence‐associated secretory phenotype and its potential as a therapeutic target for senescence‐associated diseases
por: Watanabe, Sugiko, et al.
Publicado: (2017) -
Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer
por: Purohit, Sharad, et al.
Publicado: (2020) -
Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
por: Wang, Wen-Juan, et al.
Publicado: (2017) -
Senescence-activated enhancer landscape orchestrates the senescence-associated secretory phenotype in murine fibroblasts
por: Guan, Yiting, et al.
Publicado: (2020)